During the developing COVID-19 pandemic, the Nuffield Department of Medicine Research Building is taking measures to prevent the spread of the disease.
Departments are instructed by the University's Registrar to continue to work from home where possible, and manage the return to on site working, based on the University guidelines for risk assessments and work prioritisation.
This is to restrict contact between individuals as far as possible. The University remains open and operating as far as possible with the following restrictions:
- No public access to the University
- On-site activity permitted where it cannot be undertaken remotely, driven by safety, capacity and other factors such as schools reopening/other changes in government guidelines
- Teaching and assessment are undertaken remotely where possible and, depending on government guidelines, gatherings of staff and students only permitted where essential for teaching and assessment to take place
Podcast: Meet our researchers
3 August 2021
The University of Oxford and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the vaccine available to the world, on a not-for-profit basis during the pandemic, and in perpetuity for low- and middle-income countries.
Proteomic Signature of Dysfunctional Circulating Endothelial Colony‐Forming Cells of Young Adults
Tan CMJ. et al, (2021), Journal of the American Heart Association
Cell-free DNA TAPS provides multimodal information for early cancer detection
Song C., (2021), Science Advances
Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain
Brand M. et al, (2021), Journal of Medicinal Chemistry
Therapeutic targeting of SETD2-deficient cancer cells with the small-molecule compound RITA
Lopez KA. et al, (2021)
Isoform resolved measurements of absolute translational efficiency define interplay of HIF and mTOR dysregulation in kidney cancer
Sugimoto Y. and Ratcliffe PJ., (2021)
Conformational plasticity of the ULK3 kinase domain.
Mathea S. et al, (2021), The Biochemical journal